Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein

EMBO Journal

Volumn 22, Issue 16, 2003, Pages 4249-4259

  Na, Xi ^a   Duan, Hai Ou ^a   Messing, Edward M ^a   Schoen, Susan R ^a   Ryan, Charlotte K ^a   Di Sant'Agnese, P Anthony ^a   Golemis, Erica A ^b   Wu, Guan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

hsRPB7; Proteasome; Ubiquitylation; VEGF; VHL

Indexed keywords

MESSENGER RNA; MUTANT PROTEIN; PROTEASOME; PROTEIN SUBUNIT; RNA POLYMERASE II; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA LIBRARY; ENZYME ANALYSIS; ENZYME SUBUNIT; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; TWO HYBRID SYSTEM; UBIQUITINATION; VON HIPPEL LINDAU DISEASE; WILD TYPE;

CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HIPPEL-LINDAU DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; LYMPHOKINES; MULTIENZYME COMPLEXES; MUTATION; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; PROTEINS; RNA POLYMERASE II; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; UBIQUITINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0042466570     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg410     Document Type: Article

References (39)

1. Baumeister, W., Walz, J., Zuhl, F. and Seemuller, E. (1998) The proteasome: paradigm of a self-compartmentalizing protease. Cell, 92, 367-380.
2. Choder, M. (1993) A growth rate-limiting process in the last growth phase of the yeast life cycle involves RPB4, a subunit of RNA polymerase II. J. Bacteriol., 175, 6358-6363.
3. Cockman, M.E. et al. (2000) Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem., 275, 25733-25741.
4. Cramer, P. et al. (2000) Architecture of RNA polymerase II and implications for the transcription mechanism. Science, 288, 640-649.
5. Cramer, P., Bushnell, D.A. and Kornberg, R.D. (2001) Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution. Science, 292, 1863-1876.
6. Edwards, A.M., Kane, C.M., Young, R.A. and Kornberg, R.D. (1991) Two dissociable subunits of yeast RNA polymerase II stimulate the initiation of transcription at a promoter in vitro. J. Biol. Chem., 266, 71-75.
7. Foster, K. et al. (1994) Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum. Mol. Genet., 3, 2169-2173.
8. Gnarra, J.R. et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7, 85-90.
9. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem., 67, 425-479.
10. Ivan, M. et al. (2001) HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science, 292, 464-468.
11. Iwai, K., Yamanaka, K., Kamura, T., Minato, N., Conaway, R.C., Conaway, J.W., Klausner, R.D. and Pause, A. (1999) Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl Acad. Sci. USA, 96, 12436-41.
12. 2-regulated prolyl hydroxylation. Science, 292, 468-472.
13. Jensen, G.J., Meredith, G., Bushnell, D.A. and Kornberg, R.D. (1998) Structure of wild-type yeast RNA polymerase II and location of Rpb4 and Rpb7. EMBO J., 17, 2353-2358.
14. Kamura, T. et al. (1999) Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science, 284, 657-661.
15. Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R.C. and Conaway, J.W. (2000) Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl Acad. Sci. USA, 97, 10430-10435.
16. Khazak, V., Sadhale, P.P., Woychik, N.A., Brent, R. and Golemis, E.A. (1995) Human RNA polymerase II subunit hsRPB7 functions in yeast and influences stress survival and cell morphology. Mol. Biol. Cell, 6, 759-775.
17. Khazak, V., Estojak, J., Cho, H., Majors, J., Sonoda, G., Testa, J.R. and Golemis, E.A. (1998) Analysis of the interaction of the novel RNA polymerase II (pol II) subunit hsRPB4 with its partner hsRPB7 and with pol II. Mol. Cell. Biol., 18, 1935-1945.
18. Kuznetsova, A.V., Meller, J., Schnell, P.O., Nash, J.A., Ignacak, M.L., Sanchez, Y., Conaway, J.W., Conaway, R.C. and Czyzyk-Krzeska, M.F. (2003) von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc. Natl Acad. Sci. USA, 100, 2706-2711.
19. Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M. and Krek, W. (1999) The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev., 13, 1822-1833.
20. Maher, E.R. and Kaelin, W.G., Jr (1997) von Hippel-Lindau disease. Medicine (Baltimore), 76, 381-391.
21. Maxwell, P.H. et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275.
22. McKune, K., Richards, K.L., Edwards, A.M., Young, R.A. and Woychik, N.A. (1993) RPB7, one of two dissociable subunits of yeast RNA polymerase II, is essential for cell viability. Yeast, 9, 295-299.
23. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V. and Kaelin, W.G. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol., 2, 423-427.
24. Orlicky, S.M., Tran, P.T., Sayre, M.H. and Edwards, A.M. (2001) Dissociable Rpb4-Rpb7 subassembly of RNA polymerase II binds to single-strand nucleic acid and mediates a post-recruitment step in transcription initiation. J. Biol. Chem., 276, 10097-10102.
25. Pal, S., Claffey, K.P., Cohen, H.T. and Mukhopadhyay, D. (1998) Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase Cζ. J. Biol. Chem., 273, 26277-26280.
26. Pause, A., Lee, S., Worrell, R.A., Chen, D.Y., Burgess, W.H., Linehan, W.M. and Klausner, R.D. (1997) The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl Acad. Sci. USA, 94, 2156-2161.
27. Petermann, R., Mossier, B.M., Aryee, D.N., Khazak, V., Golemis, E.A. and Kovar, H. (1998) Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene, 17, 603-610.
28. Rosenheck, S. and Choder, M. (1998) Rpb4, a subunit of RNA polymerase II, enables the enzyme to transcribe at temperature extremes in vitro. J. Bacteriol., 180, 6187-6192.
29. Sheffer, A., Varon, M. and Choder, M. (1999) Rpb7 can interact with RNA polymerase II and support transcription during some stresses independently of Rpb4. Mol. Cell. Biol., 19, 2672-2680.
30. Shen, X.Q., Bubulya, A., Zhou, X.F., Khazak, V., Golemis, E.A. and Shemshedini, L. (1999) Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription. Endocrine, 10, 281-289.
31. Shuin, T. et al. (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res., 54, 2852-2855.
32. Skowyra, D., Koepp, D.M., Kamura, T., Conrad, M.N., Conaway, R.C., Conaway, J.W., Elledge, S.J. and Harper, J.W. (1999) Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science, 284, 662-665.
33. Stebbins, C.E., Kaelin, W.G., Jr and Pavletich, N.P. (1999) Structure of the VHL-elongin C-elongin B complex: implications for VHL tumor suppressor function. Science, 284, 455-461.
34. Stolle, C. et al. (1998) Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum. Mutat., 12, 417-423.
35. Tanimoto, K., Makino, Y., Pereira, T. and Poellinger, L. (2000) Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J., 19, 4298-4309.
36. Turner, K.J. et al (2002) Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res., 62, 2957-2961.
37. Wiesener, M.S. et al. (2001) Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas. Cancer Res., 61, 5215-5222.
38. Woychik, N.A. and Young, R.A. (1989) RNA polymerase II subunit RPB4 is essential for high- and low- temperature yeast cell growth. Mol. Cell. Biol., 9, 2854-2859.
39. Young, R.A. (1991) RNA polymerase II. Annu. Rev. Biochem., 60, 689-715.